Samrat Pharmachem
add_icon

Samrat Pharmachem

206.45
+8.55
(4.32%)
Market Cap
63.84 Cr
PE Ratio
-36.51
Volume
1,795.00
Day High - Low
206.50 - 195.90
52W High-Low
425.00 - 190.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
63.84 Cr
EPS
23.02
PE Ratio
-36.51
PB Ratio
0.87
Book Value
228.74
EBITDA
11.20
Dividend Yield
0.51 %
Industry
Healthcare
Return on Equity
9.91
Debt to Equity
0.13
Forecast For
Actual

Company News

View All News
Caret
positive
Crisil Limited has upgraded Samrat Pharmachem Limited's credit rating on bank facilities to 'Crisil BB/Stable/Crisil A4+' from 'Crisil BB+/Negative/Crisil A4+', reflecting improved financial outlook.
neutral
Samrat Pharmachem Limited has scheduled its board meeting for May 30, 2026, to consider and approve audited standalone financial results for FY26 under Indian Accounting Standards.
negative
Samrat Pharmachem Limited reported a net loss of Rs 45.95 lakhs for Q3 FY26 compared to a profit of Rs 278.48 lakhs in Q3 FY25. Revenue remained flat at Rs 6,382.71 lakhs versus Rs 6,366.53 lakhs year-on-year.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,693.60
#1 4,06,351.37
37.86
#1 54,729.00
9.71
#1 10,980
16.07
37.98
5,856.50
1,55,471.67
63.26
9,712.00
18.67
2,191
-1.02
33.24
3,987.20
1,34,944.97
61.20
11,539.40
6.99
1,911
26.24
32.75
2,274.50
1,03,954.48
22.26
22,909.50
13.74
3,306
#1 37.44
47.35
1,217.30
1,01,601.09
18.27
33,741.20
16.73
5,725
-15.28
39.36
1,192.40
96,319.77
21.31
28,409.50
7.12
5,291
-57.18
26.86
864.25
86,963.77
#1 17.29
23,511.00
18.55
4,615
-0.32
41.42
1,998.50
82,499.09
45.81
12,744.20
#1 20.90
2,007
7.65
41.40
1,333.70
77,461.51
22.37
32,345.60
9.43
3,484
7.59
64.38
5,258.00
62,867.28
25.87
13,458.30
3.70
2,216
1.90
42.54
Growth Rate
Revenue Growth
1.34 %
Net Income Growth
222.73 %
Cash Flow Change
-207.23 %
ROE
197.60 %
ROCE
199.19 %
EBITDA Margin (Avg.)
187.50 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
48
62
71
93
112
138
180
222
311
283
287
290
Expenses
46
61
67
87
108
131
170
198
287
279
276
290
EBITDA
2
1
4
6
4
7
9
25
24
4
11
0
Operating Profit %
2 %
2 %
5 %
6 %
3 %
5 %
5 %
11 %
8 %
1 %
4 %
-0 %
Depreciation
0
0
0
0
0
0
1
1
1
1
1
1
Interest
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
1
0
3
5
2
6
7
24
23
3
10
-2
Tax
0
0
1
2
1
2
2
6
6
0
3
0
Net Profit
0
0
2
3
2
4
5
17
17
2
7
-2
EPS in ₹
1.02
0.97
5.68
10.41
4.97
13.71
17.26
55.62
53.83
7.00
23.02
-5.40

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
26
36
36
41
40
58
57
85
117
122
122
Fixed Assets
7
7
7
7
7
7
9
10
11
11
11
Current Assets
19
28
28
33
33
50
47
71
99
103
103
Capital Work in Progress
0
0
0
0
0
1
0
0
0
0
0
Investments
0
2
0
0
0
0
0
0
2
3
4
Other Assets
19
27
29
34
33
50
48
75
104
108
107
Total Equity & Liabilities
26
36
36
41
40
58
57
85
117
122
122
Current Liabilities
12
21
19
21
19
34
27
37
53
56
50
Non Current Liabilities
1
2
2
1
1
0
0
1
0
0
0
Total Equity
14
14
15
19
20
24
30
47
63
65
72
Reserve & Surplus
10
11
12
15
17
21
27
44
60
62
69
Share Capital
3
3
3
3
3
3
3
3
3
3
3

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-0
-1
-1
1
-1
0
15
-3
-2
-10
Investing Activities
0
-2
1
-2
2
-2
-3
-1
-3
-0
0
Operating Activities
-1
-0
-3
0
2
-1
5
18
-9
9
-10
Financing Activities
0
2
1
2
-4
2
-2
-2
10
-11
1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
49.30 %
49.30 %
49.30 %
49.65 %
49.65 %
49.65 %
49.54 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.95 %
49.09 %
49.09 %
49.09 %
49.09 %
49.09 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.24 %
3.24 %
3.24 %
3.24 %
3.24 %
0.00 %
3.24 %
3.24 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.22 %
0.22 %
0.22 %
0.00 %
0.00 %
3.24 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
42.44 %
42.93 %
42.96 %
41.06 %
37.41 %
36.70 %
37.09 %
37.89 %
38.48 %
38.81 %
42.58 %
42.61 %
41.69 %
40.79 %
41.34 %
41.95 %
41.58 %
41.64 %
41.73 %
41.50 %
Others
8.26 %
7.77 %
7.74 %
9.29 %
12.95 %
13.65 %
13.37 %
13.47 %
12.88 %
12.55 %
8.78 %
8.75 %
6.22 %
7.11 %
6.25 %
5.72 %
6.09 %
6.04 %
5.95 %
6.17 %
No of Share Holders
2,885
5,189
5,214
4,846
4,675
4,768
7,390
8,040
8,039
7,938
8,445
8,065
7,478
7,169
6,984
6,844
6,785
6,752
6,699
6,488

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 1 1 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.28 0.3 0.32 0.51 0.00

Announcements

Announcement under Regulation 30 (LODR)-Credit Rating5 days ago
Closure of Trading Window10 days ago
Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31 202610 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayFeb 13, 2026
Un-Audited Financial Results For The Quarter Ended December 31 2025Feb 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2025Dec 29, 2025
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Credit RatingDec 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 20, 2025
Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayNov 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Corporate Action-Board approves DividendSep 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30 2025Sep 26, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
Book Closure: Friday September 19 2025 To Thursday September 25 2025 (Both Days Inclusive)Sep 04, 2025
Record Date - Thursday September 18 2025Sep 04, 2025
Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday September 25 2025Sep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Un-Audited Financial Results For The Quarter Ended June 30 2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 16, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 01, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 26, 2025
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 30-06-2025Jun 23, 2025
Closure of Trading WindowJun 23, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2025
Audited Financial Results For The Year Ended March 31 2025May 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Board Meeting Intimation for Notice Of Board Meeting For Approval Of Audited Financial Results For The Financial Year Ended March 31 2025Mar 26, 2025
Closure of Trading WindowMar 20, 2025
Integrated Filing (Financial)Mar 04, 2025
General Announcement-Outcome Of Board Meeting (14-02-2025)Feb 14, 2025
Outcome Of The Board Meeting Held Today - 14-02-2024Feb 14, 2025
Approval Of Un-Audited Financial Results For The Quarter Ended December 31 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayFeb 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 13, 2025
Closure of Trading WindowDec 31, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2024Dec 31, 2024

Technical Indicators

RSI(14)
Neutral
49.67
ATR(14)
Less Volatile
12.12
STOCH(9,6)
Neutral
29.02
STOCH RSI(14)
Neutral
28.89
MACD(12,26)
Bearish
-0.32
ADX(14)
Weak Trend
11.95
UO(9)
Bearish
39.55
ROC(12)
Downtrend And Accelerating
-2.55
WillR(14)
Neutral
-45.17